Applied DNA Sciences, Inc.
APDN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $44 | $4,822 | $8,647 |
| - Cash | $5 | $7 | $9 | $6 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | -$1 | $38 | $4,814 | $8,641 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -69% | -17.8% | 47.2% | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 1.7% | 37.7% | 57.2% | 30.1% |
| EBITDA | -$4 | -$3 | -$3 | -$3 |
| % Margin | -1,187.8% | -327.2% | -242.8% | -392.8% |
| Net Income | -$4 | -$27 | -$3 | -$3 |
| % Margin | -1,296.1% | -2,768.4% | -220.6% | -405.5% |
| EPS Diluted | -34 | -15.35 | -0.56 | -0.19 |
| % Growth | -121.5% | -2,641.1% | -194.7% | – |
| Operating Cash Flow | -$3 | -$3 | -$3 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$3 | -$3 | -$4 |